PhD Candidate in advanced immune competent liver models (ref 307570)

EURAXESS Ireland; Oslo; Hybrid; NOK 520,000 - 560,000; Full time

Job summary

The University of Oslo invites applications for a PhD position within the NAM liver model project under the Emerging Technologies Initiative. The successful candidate will develop organoid- and microphysiological system-based methods to study liver-immune cross-talk and tissue homeostasis.

The PhD will focus on building a robust microfluidic platform for in‑depth analysis of liver-immune cell interactions, contributing to advances in NAM technologies and translational health research.

Job description

Organisation/Company University of Oslo Research Field Medical sciences Researcher Profile First Stage Researcher (R1) Positions PhD Positions Application Deadline 28 Sep 2026 - 23:00 (Europe/Oslo) Country Norway Type of Contract Temporary Job Status Full-time Hours Per Week 37.5 Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No

The recruited candidate will take part in UiO Emerging Technologies Initiative Project FTI-NAM. NAM technologies (New Approach Methodologies), in particular organoids and microphysiological systems (MPS), are rapidly emerging as transformative and strategic technologies with the potential to redefine the future of health and life sciences. By integrating stem cell biology, patient-derived material, tissue engineering, microfluidics, advanced analytics, and digital technologies, NAM platforms enable the development of highly predictive and human-relevant biomedical models that overcome major limitations of conventional animal models. The recruited candidate will focus on the development of an advanced human liver model for investigation of liver-immune cross-talk and the capacity of the liver to resolve inflammation and restore tissue homeostasis.

The PhD will focus on developing a robust, microfluidic platform for in‑depth analysis of liver - immune cell interactions.